statistiche ricercatore

Continente	#
NA - Nord America	544
EU - Europa	375
AS - Asia	331
SA - Sud America	49
Continente sconosciuto - Info sul continente non disponibili	32
AF - Africa	5
OC - Oceania	2
Totale	1.338

Nazione	#
US - Stati Uniti d'America	520
SG - Singapore	144
IT - Italia	124
CN - Cina	57
IE - Irlanda	55
VN - Vietnam	49
RU - Federazione Russa	36
HK - Hong Kong	35
DE - Germania	34
BR - Brasile	33
FI - Finlandia	27
FR - Francia	24
RO - Romania	21
CA - Canada	15
SE - Svezia	13
GB - Regno Unito	10
IN - India	10
KR - Corea	9
BD - Bangladesh	8
PL - Polonia	7
AR - Argentina	5
CZ - Repubblica Ceca	5
MX - Messico	5
AT - Austria	4
EC - Ecuador	4
UA - Ucraina	4
CO - Colombia	3
KE - Kenya	3
NP - Nepal	3
PK - Pakistan	3
TR - Turchia	3
AU - Australia	2
BE - Belgio	2
ES - Italia	2
MY - Malesia	2
NL - Olanda	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
AZ - Azerbaigian	1
BO - Bolivia	1
CH - Svizzera	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
EG - Egitto	1
GD - Grenada	1
GT - Guatemala	1
HN - Honduras	1
HR - Croazia	1
ID - Indonesia	1
IM - Isola di Man	1
JO - Giordania	1
LT - Lituania	1
PE - Perù	1
PH - Filippine	1
PT - Portogallo	1
PY - Paraguay	1
SC - Seychelles	1
VE - Venezuela	1
Totale	1.307

Nome	#
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia	187
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD	130
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia	128
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse	123
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention	121
T regulatory cell separation for clinical application.	117
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY	113
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs)	107
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse	103
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation	95
New mechanism of lymphoma-induced bone marrow aplasia	94
A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone	20
Totale	1.338

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	102	0	0	0	2	4	0	1	20	2	24	21	28
2022/2023	162	9	41	0	10	15	14	0	5	57	1	8	2
2023/2024	110	4	10	0	10	0	4	30	3	5	4	21	19
2024/2025	208	5	28	9	8	27	8	8	20	31	8	38	18
2025/2026	488	31	34	28	64	66	37	69	32	47	56	11	13
2026/2027	109	13	13	27	56	0	0	0	0	0	0	0	0
Totale													1.338

IRIS - Res&Arch Institutional Research Information System - Research & Archive